A retrospective, multicentre, observational study analysing outcomes in severe community-acquired pneumonia patients treated with Ceftaroline
Latest Information Update: 19 Nov 2021
At a glance
- Drugs Ceftaroline fosamil (Primary) ; Antibacterials
- Indications Community-acquired pneumonia
- Focus Therapeutic Use
- 12 Nov 2021 Results evaluating the in-hospital mortality of community-acquired pneumonia (CAP) treated with ceftaroline in comparison with standard therapy published in the European Journal of Clinical Microbiology and Infectious Diseases
- 12 Feb 2021 New trial record